Nicorette Invisi (Nicotine)

Nicotine, the active ingredient in Nicorette Invisi, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers who wish to quit by reducing nicotine withdrawal symptoms and cravings during the cessation process.

GNH USA supplies Nicorette Invisi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide, with distribution across EU and other global markets. The company ensures quality compliance with EU regulations and provides reliable logistics for institutional buyers.

Nicorette Invisi, a nicotine replacement therapy, is used in smoking cessation to manage nicotine dependence. - Smoking cessation: assists adults in quitting tobacco by alleviating cravings and withdrawal symptoms. - Nicotine dependence: provides a controlled nicotine dose to reduce the urge to smoke during the quitting process. - Relapse prevention: supports individuals who have stopped smoking to maintain abstinence and avoid relapse.

The transdermal nicotine patch may cause a range of skin‑related and systemic reactions, which are categorized by frequency and severity.

Common Side Effects: - Skin irritation at application site: redness, itching, or mild rash. - Sleep disturbance: difficulty falling asleep or staying asleep. - Vivid dreams: unusually intense or memorable dreams. - Headache: mild to moderate headache. - Nausea: feeling of queasiness. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or difficulty breathing. - Severe skin rash: extensive erythema or blistering. - Chest pain: persistent or worsening discomfort. - Hypertension: sudden increase in blood pressure. - Respiratory depression: slowed breathing. - Syncope: fainting episodes.

When using Nicorette Invisi, certain precautions should be observed to ensure safe and effective therapy. - Cardiovascular assessment: evaluate patients with heart disease before initiating therapy. - Skin condition: avoid applying the patch to irritated, damaged, or infected skin. - Heat exposure: do not expose the patch to external heat sources such as heating pads or hot tubs. - Concomitant nicotine products: do not use other nicotine replacement products simultaneously. - Duration of use: follow prescriber guidance on total treatment length to prevent dependence. - Store at room temperature: keep the patches in the original packaging, protected from moisture and direct sunlight.

Nicotine patches can interact with other medicines, altering their effects or increasing adverse reactions.

Major Interactions (Avoid): - Combined nicotine products: using cigarettes, e‑cigarettes, or other nicotine replacement therapies can lead to nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): may increase the risk of hypertension. - Certain cardiovascular drugs (e.g., beta‑blockers): concurrent use may exacerbate blood pressure changes.

Moderate Interactions (Monitor Closely): - Caffeine: nicotine may enhance stimulant effects, causing jitteriness. - Antidepressants (SSRIs, SNRIs): monitor for increased anxiety or insomnia. - Anticoagulants (warfarin): nicotine may affect platelet function; observe coagulation parameters. - Hormonal contraceptives: nicotine can reduce efficacy; advise alternative methods.